AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,000 | -20.0% | 2,777 | -15.8% | 0.00% | – |
Q2 2023 | $10,000 | +233.3% | 3,299 | +179.6% | 0.00% | – |
Q1 2023 | $3,000 | +50.0% | 1,180 | 0.0% | 0.00% | – |
Q4 2022 | $2,000 | -33.3% | 1,180 | +18.0% | 0.00% | – |
Q3 2022 | $3,000 | -82.4% | 1,000 | -78.3% | 0.00% | – |
Q2 2022 | $17,000 | -37.0% | 4,600 | -32.4% | 0.00% | – |
Q1 2022 | $27,000 | -56.5% | 6,800 | -46.3% | 0.00% | – |
Q4 2021 | $62,000 | -38.0% | 12,659 | -15.0% | 0.00% | – |
Q3 2021 | $100,000 | -16.0% | 14,898 | -0.7% | 0.00% | – |
Q2 2021 | $119,000 | -39.0% | 15,004 | -41.4% | 0.00% | – |
Q1 2021 | $195,000 | +4775.0% | 25,583 | +2711.3% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 910 | +381.5% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 189 | -61.5% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 491 | +94.1% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 253 | -41.2% | 0.00% | – |
Q1 2019 | $2,000 | – | 430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Duquesne Family Office | 1,500,000 | $24,705,000 | 2.18% |
Monashee Investment Management LLC | 275,000 | $4,529,000 | 1.59% |
SPHERA FUNDS MANAGEMENT LTD. | 79,800 | $1,314,000 | 0.21% |
Hillhouse Capital Management | 550,000 | $9,059,000 | 0.18% |
Temasek Holdings (Private) Ltd | 1,337,500 | $22,029,000 | 0.18% |
PointState Capital LP | 425,000 | $7,000,000 | 0.07% |
Artal Group S.A. | 150,000 | $2,471,000 | 0.05% |
HIGHLAND CAPITAL MANAGEMENT LP | 87,900 | $1,448,000 | 0.04% |
Schonfeld Strategic Advisors LLC | 14,779 | $243,000 | 0.04% |
Point72 Hong Kong Ltd | 4,000 | $66,000 | 0.04% |